Hepion Pharmaceuticals Faces Delisting Notice
Ticker: CTRVP · Form: 8-K · Filed: Jan 15, 2025 · CIK: 1583771
| Field | Detail |
|---|---|
| Company | Hepion Pharmaceuticals, Inc. (CTRVP) |
| Form Type | 8-K |
| Filed Date | Jan 15, 2025 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Hepion Pharmaceuticals got a delisting notice, might be in trouble.
AI Summary
Hepion Pharmaceuticals, Inc. filed an 8-K on January 15, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company was formerly known as ContraVir Pharmaceuticals, Inc. and is incorporated in Delaware.
Why It Matters
This filing indicates potential issues with Hepion Pharmaceuticals' continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's ability to remain publicly traded.
Key Players & Entities
- Hepion Pharmaceuticals, Inc. (company) — Registrant
- ContraVir Pharmaceuticals, Inc. (company) — Former company name
- January 14, 2025 (date) — Earliest event reported
- January 15, 2025 (date) — Filing date
- 001-36856 (other) — SEC File Number
FAQ
What is the specific reason for Hepion Pharmaceuticals' notice of delisting or failure to satisfy a continued listing rule?
The filing does not specify the exact reason for the delisting notice, only that it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard'.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on January 14, 2025.
What was Hepion Pharmaceuticals' former company name?
Hepion Pharmaceuticals, Inc. was formerly known as ContraVir Pharmaceuticals, Inc.
In which state is Hepion Pharmaceuticals, Inc. incorporated?
Hepion Pharmaceuticals, Inc. is incorporated in Delaware.
What is the SEC file number for Hepion Pharmaceuticals, Inc.?
The SEC file number for Hepion Pharmaceuticals, Inc. is 001-36856.
Filing Stats: 567 words · 2 min read · ~2 pages · Grade level 13.9 · Accepted 2025-01-15 16:15:15
Key Financial Figures
- $0.0001 — h registered: Common Stock, par value $0.0001 per share HEPA The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 35KB
- 0001493152-25-002377.txt ( ) — 206KB
- hepa-20250114.xsd (EX-101.SCH) — 3KB
- hepa-20250114_lab.xml (EX-101.LAB) — 33KB
- hepa-20250114_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 15, 2025 Hepion Pharmaceuticals, Inc. By: /s/ John Brancaccio John Brancaccio Interim Chief Executive Officer and Interim Chief Financial Officer -3-